Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
Details for Australian Patent Application No. 2009202900 (hide)
International Classifications
Event Publications
30 July 2009 Complete Application Filed
6 August 2009 Application Open to Public Inspection
Published as AU-B-2009202900
11 February 2010 Application Accepted
Published as AU-B-2009202900
3 June 2010 Corrigenda
Applications Accepted - Name Index Under the Name Arena Pharmaceuticals, Inc., Application No. 2009202900, under INID (72) correct the inventor to read Al-Shamma, Hussein A. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2004216002 The Trustees of the University of Pennsylvania 2004297504 W.R. Grace & Co.-Conn. 2005205373 Cyrium Technologies Incorporated 2005254927 A
10 June 2010 Standard Patent Sealed
19 August 2010 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Al-Shamma, Hussein A. to Al-Shamma, Hussien A.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009202901-Trenching and Concreting Machine
2009202899-Double conversion cheque-clearing process and system
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser